Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +40.37%
#2 Bitway Bitway +24.69%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.60%
#4 Starpower Starpower +20.94%
#5 aelf aelf +17.84%
#6 Pons Pons +15.88%
#7 Venom Venom +14.34%
#8 Decred Decred +14.08%
#9 DAPPOS DAPPOS +12.84%
#10 Wibx Wibx +8.12%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
Radiopharm Theranostics Limited Radiopharm Theranostics Limited

Radiopharm Theranostics Limited

RAD
Rank in Stocks #30071
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company,... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia.
Share Price
$0.00775813
Market Cap
$18.35M
Change (1 day)
-8.33%
Change (1 year)
-51.93%
Country
AU
Trade Radiopharm Theranostics Limited (RAD)

Category

Healthcare
Stock price history for Radiopharm Theranostics Limited (RAD)
Highest end of day price: $0.01 on 2026-08-01

Lowest end of day price: $0.24 on 2021-11-01
Stock price history of Radiopharm Theranostics Limited from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -22.82%
2025 -10.60%
2024 -63.52%
2023 -27.28%
2022 -71.97%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.09%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 51.72%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $116.20 -20.17%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.07%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 14.92%
BE